Cryolife broke a downward trend today. It is a strong buy by Yahoo Financial
"Coming to projected sales, the stock holds a growth rate of 25.16% for the current year, compared with the industry’s 6.47%. CryoLife registered positive earnings surprises in the last four quarters, the average being 333.75%.
CryoLife reported stellar third-quarter results, with adjusted earnings of 13 cents per share crushing the Zacks Consensus Estimate of 4 cents. Revenues of $45.3 million were in line with the estimate mark, but increased almost 21.6% on a year-over-year basis."
"Coming to projected sales, the stock holds a growth rate of 25.16% for the current year, compared with the industry’s 6.47%. CryoLife registered positive earnings surprises in the last four quarters, the average being 333.75%.
CryoLife reported stellar third-quarter results, with adjusted earnings of 13 cents per share crushing the Zacks Consensus Estimate of 4 cents. Revenues of $45.3 million were in line with the estimate mark, but increased almost 21.6% on a year-over-year basis."